PRDM2 and malignant mesothelioma: Whole-genome sequencing of blood and cancerous tissues from patients with malignant mesothelioma of the vaginal testicular membrane reveals mutations in the PRDM2 gene, suggesting that PRDM2 may serve as a target for the development of malignant mesothelioma of the vaginal testicular membrane [62].